Kaiming Ye
Professor and Department Chair
State University of New York Department of Bioengineering
USA
Biography
Dr. Kaiming Ye is a professor and chair, Department of Biomedical Engineering, Watson School of Engineering and Applied Science, Binghamton University, SUNY. Before he joined Binghamton University, he was program director for the Biomedical Engineering Program at the National Science Foundation (NSF), managing the biomedical engineering and health science funding program. His research interests focus on stem cell and regenerative medicine and 3D tissue and organ printing. He has published one book, one patent and more than 66 papers in the field. He is best known for his creative work developing 3D scaffolds for directing stem cell pancreatic differentiation, creating fluorescence nanosensors for both in vivo and in vitro continuous glucose monitoring, and formulating recombinant yeast influenza vaccines. His research has been continuously funded by NIH, NSF, JDRF, ABI and industries. He serves as executive/associate editor and editorial board member of 12 journals and has been invited to deliver keynote/plenary speeches at numerous international and national conferences. He has also served on numerous review panels and study sections for NIH and NSF. He is also program evaluator of ABET accreditation for Biomedical Engineering Programs.
Research Interest
Develop 3D tissue engineered scaffolds for directing lineage-specific differentiation of human embryonic and induced pluripotent stem (ES/iPS) cells into clinically-relevant cell lineages for cell replacement therapy., Build biomimetic multicellular systems for organ development and regeneration., Create fluorescent nanosensors for in vivo tracking stem cell proliferation and differentiation., Advance nanoparticle-based controlled and targeted drug delivery for cancer treatment., Develop implantable glucose sensors for continuous blood glucose monitoring in diabetic patients., Engineer fluorescence nanaosensors for real-time measurement of glucose transport in insulin-resistance tissues and cells by visualizing glucose dynamics in these cells through fluorescence lifetime imaging microscopy (FLIM) measurement.